Disarming Pancreatic Cancer With Enzyme Inhibitors
Researchers at West Virginia University are advancing pancreatic cancer treatment by targeting a specific enzyme, ...
Buy Rating Justified by Promising CM24 Phase 2 Study for Pancreatic Cancer Survival
Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Purple Biotech (PPBT – Research Report). The associated price ...
Medscape5 天
AI-Driven Data Analysis Identifies Five Unique Clusters in ANCA-Associated Vasculitis
A data-driven analysis of a large cohort of patients with ANCA-associated vasculitis subclassified the condition into five ...
Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study ...
High CEACAM1 and low PDL1 expression in tumors, as well as their combination identified as potential biomarkers associated ...
Yahoo Finance6 天
Purple Biotech Ltd (1YI1.DU)
These are the upcoming stock splits for the week of September 16 to September 20, based on TipRanks’ Stock Splits Calendar. A stock split is a corporate action in which the company issues additional ...